Back
Cassava Sciences Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
19
SAVA
Cassava Sciences
Last Price:
$2.36
Seasonality Move:
34.39%
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.12
Seasonality Move:
7.64%
Sell
19
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
-
The current Cassava Sciences [SAVA] share price is $2.36. The Score for SAVA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
SAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $2.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight buying pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $7.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.77 | Sell |
Relative Strength Index (14 RSI): | 22.86 | Sell |
Chaikin Money Flow: | 1414507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-1.63 - 19.71) | Sell |
Bollinger Bands (100): | (13.1 - 32.86) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 34.11 | Sell |
Chaikin Money Flow: | -639404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.76 - 9.04) | Sell |
Bollinger Bands (100): | (7.84 - 10.36) | Sell |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.58 | Sell |
20-day SMA: | 4.25 | Sell |
50-day SMA: | 17.9 | Sell |
200-day SMA: | 21.04 | Sell |
8-day EMA: | 2.78 | Sell |
20-day EMA: | 6.44 | Sell |
50-day EMA: | 14.12 | Sell |
200-day EMA: | 20.57 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.62 | Sell |
20-day SMA: | 8.29 | Sell |
50-day SMA: | 9.7 | Sell |
200-day SMA: | 11.63 | Sell |
8-day EMA: | 7.61 | Sell |
20-day EMA: | 8.25 | Sell |
50-day EMA: | 8.98 | Sell |
200-day EMA: | 10.9 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.37 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Cassava Sciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |